Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Income Statement
Earnings Waterfall
Fusion Pharmaceuticals Inc
Revenue
|
2.1m
USD
|
Operating Expenses
|
-101.3m
USD
|
Operating Income
|
-99.2m
USD
|
Other Expenses
|
4.3m
USD
|
Net Income
|
-94.9m
USD
|
Income Statement
Fusion Pharmaceuticals Inc
Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
+63%
|
1
+69%
|
2
+41%
|
2
+2%
|
2
-8%
|
1
-24%
|
1
-38%
|
0
-59%
|
2
+497%
|
2
-6%
|
|
Operating Income | ||||||||||||||||
Operating Expenses |
(16)
|
(26)
|
(38)
|
(47)
|
(67)
|
(77)
|
(83)
|
(87)
|
(79)
|
(83)
|
(90)
|
(93)
|
(100)
|
(98)
|
(101)
|
|
Selling, General & Administrative |
(8)
|
(14)
|
(21)
|
(23)
|
(26)
|
(27)
|
(27)
|
(29)
|
(30)
|
(30)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
|
Research & Development |
(8)
|
(12)
|
(17)
|
(24)
|
(41)
|
(50)
|
(56)
|
(58)
|
(49)
|
(53)
|
(59)
|
(62)
|
(69)
|
(67)
|
(70)
|
|
Operating Income |
(16)
N/A
|
(26)
-64%
|
(38)
-44%
|
(47)
-24%
|
(67)
-43%
|
(76)
-14%
|
(82)
-8%
|
(85)
-3%
|
(77)
+9%
|
(81)
-6%
|
(88)
-8%
|
(92)
-5%
|
(100)
-8%
|
(95)
+4%
|
(99)
-4%
|
|
Pre-Tax Income | ||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
(1)
|
(2)
|
(2)
|
0
|
3
|
4
|
|
Total Other Income |
(39)
|
(39)
|
(38)
|
(37)
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
|
Pre-Tax Income |
(55)
N/A
|
(65)
-19%
|
(76)
-17%
|
(83)
-10%
|
(65)
+21%
|
(75)
-14%
|
(81)
-9%
|
(84)
-3%
|
(77)
+8%
|
(82)
-7%
|
(89)
-9%
|
(94)
-5%
|
(99)
-6%
|
(92)
+7%
|
(94)
-2%
|
|
Net Income | ||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(3)
|
(3)
|
(2)
|
(3)
|
0
|
0
|
1
|
2
|
2
|
2
|
1
|
1
|
(1)
|
|
Income from Continuing Operations |
(55)
|
(65)
|
(78)
|
(86)
|
(68)
|
(77)
|
(81)
|
(83)
|
(76)
|
(80)
|
(88)
|
(92)
|
(98)
|
(91)
|
(95)
|
|
Net Income (Common) |
(56)
N/A
|
(66)
-18%
|
(80)
-20%
|
(86)
-7%
|
(68)
+21%
|
(77)
-14%
|
(81)
-5%
|
(83)
-3%
|
(76)
+9%
|
(80)
-6%
|
(88)
-9%
|
(92)
-5%
|
(98)
-7%
|
(91)
+7%
|
(95)
-4%
|
|
EPS (Diluted) |
-1.35
N/A
|
-1.59
-18%
|
-1.91
-20%
|
-2.05
-7%
|
-1.61
+21%
|
-1.79
-11%
|
-1.9
-6%
|
-1.94
-2%
|
-1.75
+10%
|
-1.85
-6%
|
-2
-8%
|
-1.71
+15%
|
-1.48
+13%
|
-1.32
+11%
|
-1.45
-10%
|